Search
Search Results
##search.searchResults.foundPlural##
-
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1334PDF: 608HTML: 3398 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1235PDF: 611HTML: 6806 -
GROWTH AND ENDOCRINE FUNCTION IN TUNISIAN THALASSEMIA MAJOR PATIENTS
3150PDF: 1042HTML: 427TABLE: 199FIGURES: 267 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3627PDF: 1543HTML: 4442CoverLetter: 191Figure1: 204 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1212PDF: 847HTML: 2190Figue 1: 182 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2224PDF: 1636HTML: 323 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
2004PDF: 832HTML: 2208Table 1: 191Table 2: 209Table 3: 204Table 4: 206Table 5: 204Tble 6: 198Cover Letter: 216Greene Tab.7: 207 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3809PDF: 1617HTML: 586Figures . Eliassian: 233 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3632PDF: 2553HTML: 1525 -
-
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3427PDF: 1503HTML: 4017 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1842PDF: 1188HTML: 258 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1677PDF: 606HTML: 238 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1245PDF: 937HTML: 293 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2528PDF: 1334HTML: 1803CoverLetter: 191 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2162PDF: 1561HTML: 538 -
-
-
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4895PDF: 2896HTML: 2320 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2923PDF: 976HTML: 7354 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
4983PDF: 1334HTML: 1924Untitled: 190Untitled: 186 -
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
2045PDF: 98HTML: 27 -
-
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2336PDF: 1347HTML: 17105Bassan Fig.1: 154Bassan Fig.2: 168Bassan Fig.4: 145Fig.3: 214 -
-







